Pheast Therapeutics

CARISMA Therapeutics

This company develops engineered macrophage and monocyte cell therapies to treat patients with solid tumours and liver fibrosis.

Pheon Therapeutics

The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Macomics

The company develops macrophage-modulating antibody therapies and precision medicines for patients with cancer and fibrotic diseases.

Carisma Theraputics

The company develops engineered macrophage and monocyte cell therapies for patients with solid tumours, liver fibrosis and other serious diseases.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.